Umuthi Womkhuhlane, Live Intranasal

Umuthi wokugomela umkhuhlane ungavimbela umkhuhlane (umkhuhlane).

Umkhuhlane yisifo esithathelwanayo esisakazeka minyaka yonke e-United States, ngokuvamile phakathi kuka-Okthoba noMeyi. Noma ngubani angawuthola umkhuhlane, kodwa kuyingozi kakhulu kwabanye abantu. Izinsana nezingane ezincane, abantu abaneminyaka engama-65 ubudala nangaphezulu, abesifazane abakhulelwe, nabantu abanezimo ezithile zezempilo noma amasosha omzimba abuthakathaka basengozini enkulu yokuba nezinkinga zomkhuhlane.

I-pneumonia, i-bronchitis, ukutheleleka kwe-sinus nokutheleleka ezindlebeni kuyizibonelo zezinkinga ezihlobene nomkhuhlane. Uma unesimo sempilo, njengesifo senhliziyo, umdlavuza noma isifo sikashukela, umkhuhlane ungakwenza kubi kakhulu.

Umkhuhlane ungadala ukushisa komzimba nokugodola, umphimbo obuhlungu, ubuhlungu bemisipha, ukukhathala, ukukhwehlela, ikhanda elibuhlungu kanye nekhala eligobayo noma eligcwele. Abanye abantu bangaba nokuhlanza nokuhuda, kepha lokhu kuvame kakhulu ezinganeni kunabantu abadala.

Unyaka nonyaka izinkulungwane zabantu e-United States zibulawa ngumkhuhlane, kanti abanye abaningi balaliswa ezibhedlela. Umuthi wokugomela umkhuhlane uvimbela izigidi zezifo nokuvakashelwa okuhlobene nomkhuhlane kudokotela unyaka nonyaka.

I-CDC incoma ukuthi wonke umuntu onezinyanga eziyisithupha ubudala nangaphezulu agonywe njalo isikhathi somkhuhlane. Izingane ezinyangeni eziyisithupha kuya eminyakeni eyisishiyagalombili ubudala zingadinga imithamo emi-2 ngesikhathi esisodwa somkhuhlane. Wonke umuntu udinga umthamo owodwa kuphela wesizini ngayinye yomkhuhlane.

Umuthi wokugomela umkhuhlane ophilayo, obizwa ngokuthi yi-LAIV) umuthi wokugoma ngamakhala onganikezwa abantu abangakhulelwe abaneminyaka engu-2 kuya kwengama-49 ubudala.

Kuthatha cishe amasonto amabili ukuvikela ukukhula ngemuva kokugoma.

Kunamagciwane amaningi omkhuhlane, futhi ahlala eshintsha. Unyaka nonyaka kwenziwa umuthi wokugomela umkhuhlane omusha ukuvikela amagciwane amathathu noma amane okungenzeka ukuthi abanga izifo esikhathini esizayo somkhuhlane. Noma umuthi wokugoma ungahambisani ncamashi nala magciwane, usenganikeza ukuvikelwa okuthile.

Umuthi wokugomela umkhuhlane awubangeli umkhuhlane.

Umuthi wokugomela umkhuhlane unganikezwa ngasikhathi sinye neminye imigomo.

Tshela umhlinzeki uma umuntu othola umuthi wokugoma:

• Uneminyaka engaphansi kwengu-2 noma ngaphezulu kuneminyaka engama-49 ubudala.
• Ukhulelwe.
• Uye waba nokungezwani komzimba ngemuva komthamo wangaphambilini womuthi wokugomela umkhuhlane, noma uneminye yemizimba emibi, esongela impilo.
• Ingabe ingane noma eyeve eshumini nambili eneminyaka engu-17 ukuya kwengu-17 ethola ama-aspirin noma imikhiqizo equkethe ama-aspirin.
• Inamasosha omzimba abuthakathaka.
• Ingabe ingane eneminyaka engu-2 kuya kwengu-4 ubudala enesifuba somoya noma umlando wokuphefumula ezinyangeni eziyi-12 ezedlule.
• Uthathe umuthi womkhuhlane we-antiviral emahoreni angama-48 edlule.
• Inakekela abantu abagonyelwe kanzima abadinga indawo evikelekile.
• Ineminyaka emi-5 noma ngaphezulu futhi inesifuba somoya.
• Inezinye izimo zezokwelapha ezingaphansi ezingabeka abantu engcupheni enkulu yezinkinga ezibucayi zomkhuhlane (njengesifo samaphaphu, isifo senhliziyo, isifo sezinso, ukuphazamiseka kwezinso noma kwesibindi, i-neurologic noma i-neuromuscular or metabolic disorders).
• Ube neGuillain-Barré Syndrome kungakapheli amasonto ayisithupha ngemuva komthamo wangaphambilini wokugomela umkhuhlane.

Kwezinye izimo, umhlinzeki wakho wezokunakekelwa kwempilo anganquma ukuhlehlisa ukugomela umkhuhlane ekuhambeleni okuzayo.

Kwezinye iziguli, uhlobo oluhlukile lomuthi wokugomela umkhuhlane (umuthi wokugomela umkhuhlane ongasebenzi noma owakhiwe kabusha) lungalunga ukwedlula umuthi wokugomela umkhuhlane ophilayo.

Abantu abanezifo ezincane, njengomkhuhlane, bangagonywa. Abantu abagula ngokulingene noma kakhulu kufanele bavame ukulinda baze balulame ngaphambi kokuthola umuthi wokugomela umkhuhlane.

Umhlinzeki wakho wezokunakekelwa kwempilo angakunika eminye imininingwane.

• Iphunga eligijimayo noma isiminyaminya samakhala, isifuba nekhanda kungenzeka ngemuva kwe-LAIV.
• Ukuhlanza, ubuhlungu bemisipha, umkhuhlane, umphimbo obuhlungu nokukhwehlela kungeminye yemiphumela emibi engaba khona.

Uma lezi zinkinga zenzeka, zivame ukuqala ngokushesha ngemuva kokugoma futhi ziphila isikhathi esifushane.

Njenganoma imuphi umuthi, kunethuba elikude kakhulu lomuthi wokugoma obangela ukusabela okweqile, okunye ukulimala okubi, noma ukufa.

Ukungezwani komzimba kungenzeka ngemuva kokuthi umuntu ogonyiwe ashiye umtholampilo.Uma ubona izimpawu zokungezwani komzimba (isifuba, ukuvuvukala kobuso nomphimbo, ukuphefumula kanzima, ukushaya kwenhliziyo okusheshayo, isiyezi, noma ubuthakathaka), shayela u-9-1-1 bese umyisa esibhedlela esiseduze.

Ngezinye izimpawu ezikukhathazayo, shayela umhlinzeki wakho wezokunakekelwa kwempilo.

Ukusabela okungekuhle kufanele kubikwe ku-Vaccine Adverse Event Reporting System (VAERS). Umhlinzeki wakho wezokunakekelwa kwempilo uvame ukufaka lo mbiko, noma ungazenzela ngokwakho. Vakashela iwebhusayithi ye-VAERS ku-http: //www.vaers.hhs.gov noma ushayele ku-1-800-822-7967. I-VAERS ingeyokubika kuphela ukusabela, futhi abasebenzi be-VAERS abanikeli izeluleko ngezokwelapha.

Uhlelo lweNational Vaccine Injury Compensation Program (VICP) luhlelo oludalelwe ukunxephezela abantu okungenzeka balinyazwe yimithi ethile yokugoma. Vakashela iwebhusayithi ye-VICP ku-http: //www.hrsa.gov/vaccinecompensation noma ushayele ku-1-800-338-2382 ukuze ufunde ngalolu hlelo nangokufaka isicelo sesimangalo. Kunomkhawulo wesikhathi sokufaka isicelo sesinxephezelo.

• Buza umhlinzeki wakho wezokunakekelwa kwempilo
• Shayela umnyango wezempilo wangakini noma wesifundazwe.
• Xhumana Nezikhungo Zokulawulwa Nokuvimbelwa Kwezifo (CDC): Shayela ku-1-800-232-4636 (1-800-CDC-INFO) noma uvakashele iwebhusayithi ye-CDC ku-http: //www.cdc.gov/flu

Isitatimende Sokwaziswa Sokugomela Umkhuhlane Esibukhoma. UMnyango Wezempilo WaseMelika kanye Nezinsizakalo Zabantu / Izikhungo Zokulawulwa Nokuvikelwa Kwezifo Uhlelo Lukazwelonke Lokugoma. 8/15/2019.

• I-FluMist^®